-
Job ID: 11611 Fixed term from January 1, 2026 to December 31, 2028 | Full-time with 38.5 hours per week | Salary according to TV-L | Core Unit for Stem Cell Technology We are UKM. We have a clear
-
mission is to ensure safety in technology and chemistry. We perform research and testing in materials science, materials engineering and chemistry to improve the safety of products and processes. At BAM we
-
postdoctoral position within the ERC-2024-STG-funded project 1101165141-MANAGE HSC. This project combines stem cell and stem cell niche biology, bone marrow/niche engineering, and cell mechanics to investigate
-
natural and AI-designed protein domains, along with an engineered fusogenic protein. The technology has been recognized with the m4 Award, the GO-Bio next program, and is currently under revision in a top
-
treatment of infectious diseases. The Helmholtz Biomedical Engineering initiative aims to foster new synergies by enhancing collaboration between Helmholtz Research Centres and Research Fields, while also
-
functional and phenotypic assays on human T cells (in vitro and ex vivo) Engineer T cells using mRNA delivery platforms via lipid nanoparticles Characterize T cell subsets using multiparametric flow cytometry